{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T17:59:36Z","timestamp":1789840776475,"version":"4.0.1"},"reference-count":82,"publisher":"MDPI AG","issue":"22","license":[{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Galenicum","award":["None"],"award-info":[{"award-number":["None"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Topical tretinoin (all-trans-retinoic acid) is a first-generation vitamin A derivative with well-established efficacy in acne vulgaris and photoaging. Owing to its pleiotropic effects on epidermal differentiation, collagen synthesis, and skin pigmentation, numerous off-label uses have been proposed across dermatology. This narrative review summarizes current evidence on the efficacy and safety of topical tretinoin for multiple dermatological conditions, based on studies published between January 2000 and July 2025. Robust data from randomized clinical trials (RCTs) and systematic reviews support its benefit in acne and photoaging, whereas smaller RCTs and prospective studies indicate potential efficacy for melasma, postinflammatory hyperpigmentation, striae distensae, flat warts, alopecia areata, androgenetic alopecia, hypertrophic scars and keloids, and actinic keratosis and as pretreatment before chemical peels or laser resurfacing. However, high-quality, adequately powered trials with standardized outcome measures are still needed to establish clinical guidelines. Regarding cutaneous oncology, a large RCT demonstrated no preventive effect of tretinoin on keratinocyte carcinomas. Adverse events are typically mild, localized, and transient, and available evidence does not support an association with systemic adverse effects.<\/jats:p>","DOI":"10.3390\/jcm14227958","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T15:07:31Z","timestamp":1762787251000},"page":"7958","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["An Updated Review of Topical Tretinoin in Dermatology: From Acne and Photoaging to Skin Cancer"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-1751-8959","authenticated-orcid":false,"given":"Pablo","family":"Balado-Sim\u00f3","sequence":"first","affiliation":[{"name":"Dermatology Department, Hospital Cl\u00ednic de Barcelona, Universitat de Barcelona, 08007 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Morgado-Carrasco","sequence":"additional","affiliation":[{"name":"Dermatology Department, Hospital Cl\u00ednic de Barcelona, Universitat de Barcelona, 08007 Barcelona, Spain"},{"name":"Dermatology Department, Hospital de Figueras, Fundaci\u00f3 Salut Empord\u00e0, 17600 Figueras, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"G\u00f3mez-Armayones","sequence":"additional","affiliation":[{"name":"Cl\u00ednica Corium Dermatology, 08007 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"L\u00f3pez-Ferrer","sequence":"additional","affiliation":[{"name":"Dermatology Department, Hospital de la Santa Creu i Sant Pau, 08041 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didac","family":"Barco","sequence":"additional","affiliation":[{"name":"Cl\u00ednica Corium Dermatology, 08007 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Ferr\u00e1ndiz-Pulido","sequence":"additional","affiliation":[{"name":"Dermatology Department, Hospital Universitari Vall d\u2019Hebron, 08035 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4150-0522","authenticated-orcid":false,"given":"Sebastian","family":"Podlipnik","sequence":"additional","affiliation":[{"name":"Dermatology Department, Hospital Cl\u00ednic de Barcelona, Universitat de Barcelona, 08007 Barcelona, Spain"},{"name":"Institut d\u2019Investigacions Biom\u00e8diques August Pi i Sunyer (IDIBAPS), 08036 Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,11,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e003","DOI":"10.1097\/JW9.0000000000000003","article-title":"Topical tretinoin for treating photoaging: A systematic review of randomized controlled trials","volume":"8","author":"Sitohang","year":"2022","journal-title":"Int. J. Women\u2019s Dermatol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Szyma\u0144ski, \u0141., Skopek, R., Palusi\u0144ska, M., Schenk, T., Stengel, S., Lewicki, S., Kraj, L., Kami\u0144ski, P., and Zelent, A. (2020). Retinoic Acid and Its Derivatives in Skin. Cells, 9.","DOI":"10.3390\/cells9122660"},{"key":"ref_3","first-page":"41","article-title":"Mechanisms of the comedolytic and anti-inflammatory properties of topical retinoids","volume":"4","author":"Bikowski","year":"2005","journal-title":"J. Drugs Dermatol. JDD"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/jdv.12242","article-title":"Comparative effect of topical silicone gel and topical tretinoin cream for the prevention of hypertrophic scar and keloid formation and the improvement of scars","volume":"28","author":"Kwon","year":"2014","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s00403-024-03789-1","article-title":"Evaluation of common topical therapeutic agents of plane warts","volume":"317","author":"Ali","year":"2025","journal-title":"Arch. Dermatol. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s13555-025-01344-y","article-title":"Recommendations to Improve Outcomes in Acne and Acne Sequelae: A Focus on Trifarotene and Other Retinoids","volume":"15","author":"Issa","year":"2025","journal-title":"Dermatol. Ther."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s00403-024-02931-3","article-title":"Systematic review of topical, laser, and oral treatments in acanthosis nigricans clinical trials","volume":"316","author":"Bitterman","year":"2024","journal-title":"Arch. Dermatol. Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1111\/jdv.15020","article-title":"Tretinoin (0.05% cream vs. 5% peel) for photoaging and field cancerization of the forearms: Randomized, evaluator-blinded, clinical trial","volume":"32","author":"Sumita","year":"2018","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s41073-019-0064-8","article-title":"SANRA\u2014A scale for the quality assessment of narrative review articles","volume":"4","author":"Baethge","year":"2019","journal-title":"Res. Integr. Peer Rev."},{"key":"ref_10","first-page":"152","article-title":"A double-blinded, randomized, vehicle-controlled, multicenter, parallel-group study to assess the safety and efficacy of tretinoin gel microsphere 0.04% in the treatment of acne vulgaris in adults","volume":"80","author":"Berger","year":"2007","journal-title":"Cutis"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.clinthera.2007.06.021","article-title":"Tretinoin gel microspheres 0.04% versus 0.1% in adolescents and adults with mild to moderate acne vulgaris: A 12-week, multicenter, randomized, double-blind, parallel-group, phase IV trial","volume":"29","author":"Berger","year":"2007","journal-title":"Clin. Ther."},{"key":"ref_12","first-page":"32","article-title":"Novel Tretinoin 0.05% Lotion for Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris in a Hispanic Population","volume":"18","author":"Weinkle","year":"2019","journal-title":"J. Drugs Dermatol. JDD"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1080\/09546634.2020.1720579","article-title":"Efficacy and safety comparison of combination of 0.04% tretinoin microspheres plus 1% clindamycin versus their monotherapy in patients with acne vulgaris: A phase 3, randomized, double-blind study","volume":"32","author":"Dogra","year":"2021","journal-title":"J. Dermatol. Treat."},{"key":"ref_14","first-page":"287","article-title":"A multicenter, double-blind study to evaluate the efficacy and safety of 2 treatments in participants with mild to moderate acne vulgaris","volume":"89","author":"Draelos","year":"2012","journal-title":"Cutis"},{"key":"ref_15","first-page":"1129","article-title":"Phase 4 study to assess tretinoin pump for the treatment of facial acne","volume":"7","author":"Eichenfield","year":"2008","journal-title":"J. Drugs Dermatol. JDD"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/j.1525-1470.2012.01811.x","article-title":"Tretinoin Microsphere Gel 0.04% Pump for Treating Acne Vulgaris in Preadolescents: A Randomized, Controlled Study","volume":"29","author":"Eichenfield","year":"2012","journal-title":"Pediatr. Dermatol."},{"key":"ref_17","first-page":"910","article-title":"Novel Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris in an Asian Population","volume":"18","author":"Han","year":"2019","journal-title":"J. Drugs Dermatol. JDD"},{"key":"ref_18","first-page":"1147","article-title":"Efficacy and Tolerability of a Novel Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate or Severe Acne Vulgaris in Adult Females","volume":"18","author":"Harper","year":"2019","journal-title":"J. Drugs Dermatol. JDD"},{"key":"ref_19","first-page":"1084","article-title":"Novel Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris: Assessment of Efficacy and Safety in Patients Aged 9 Years and Older","volume":"17","author":"Tyring","year":"2018","journal-title":"J. Drugs Dermatol. JDD"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s40257-020-00559-3","article-title":"The Effects of Once-Daily Tretinoin 0.05% Lotion on Quality of Life in Patients with Moderate-to-Severe Acne Vulgaris","volume":"21","author":"Tyring","year":"2020","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1468-3083.2010.03793.x","article-title":"Comparison of tretinoin 0.05% cream and 3% alcohol-based salicylic acid preparation in the treatment of acne vulgaris","volume":"25","author":"Babayeva","year":"2011","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_22","first-page":"318","article-title":"Efficacy and safety of clindamycin-tretinoin gel versus clindamycin or tretinoin alone in acne vulgaris: A randomized, double-blind, vehicle-controlled study","volume":"11","author":"Jarratt","year":"2012","journal-title":"J. Drugs Dermatol. JDD"},{"key":"ref_23","first-page":"624","article-title":"Comparative efficacy and safety results of two topical combination acne regimens","volume":"8","author":"Kircik","year":"2009","journal-title":"J. Drugs Dermatol. JDD"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"279","DOI":"10.4103\/0378-6323.51247","article-title":"Clindamycin lotion alone versus combination lotion of clindamycin phosphate plus tretinoin versus combination lotion of clindamycin phosphate plus salicylic acid in the topical treatment of mild to moderate acne vulgaris: A randomized control trial","volume":"75","author":"NilFroushzadeh","year":"2009","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"ref_25","first-page":"805","article-title":"Tretinoin gel microsphere pump 0.04% plus 5% benzoyl peroxide wash for treatment of acne vulgaris: Morning\/morning regimen is as effective and safe as morning\/evening regimen","volume":"9","author":"Pariser","year":"2010","journal-title":"J. Drugs Dermatol. JDD"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jaad.2023.05.093","article-title":"Efficacy and safety of microencapsulated benzoyl peroxide and microencapsulated tretinoin for the treatment of acne vulgaris: Results from two phase 3 double-blind, randomized, vehicle-controlled studies","volume":"89","author":"Rosso","year":"2023","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1365-2133.2011.10332.x","article-title":"Cortexolone 17\u03b1-propionate 1% cream, a new potent antiandrogen for topical treatment of acne vulgaris. A pilot randomized, double-blind comparative study vs. placebo and tretinoin 0\u00b705% cream","volume":"165","author":"Trifu","year":"2011","journal-title":"Br. J. Dermatol."},{"key":"ref_28","first-page":"619","article-title":"A phase IV, open-label study evaluating the use of triple-combination therapy with minocycline HCl extended-release tablets, a topical antibiotic\/retinoid preparation and benzoyl peroxide in patients with moderate to severe acne vulgaris","volume":"12","author":"Zaenglein","year":"2013","journal-title":"J. Drugs Dermatol. JDD"},{"key":"ref_29","first-page":"277","article-title":"Efficacy and safety of tretinoin 0.025%\/clindamycin phosphate 1.2% gel in combination with benzoyl peroxide 6% cleansing cloths for the treatment of facial acne vulgaris","volume":"12","author":"Zeichner","year":"2013","journal-title":"J. Drugs Dermatol. JDD"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1684\/ejd.2018.3320","article-title":"Comparable efficacy of adapalene 0.3% gel and tretinoin 0.05% cream as treatment for cutaneous photoaging","volume":"28","author":"Bagatin","year":"2018","journal-title":"Eur. J. Dermatol. EJD"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/jocd.12381","article-title":"Efficacy and tolerability of a double-conjugated retinoid cream vs. 1.0% retinol cream or 0.025% tretinoin cream in subjects with mild to severe photoaging","volume":"16","author":"McDaniel","year":"2017","journal-title":"J. Cosmet. Dermatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1001\/jamadermatol.2022.1891","article-title":"Biomarkers of Tretinoin Precursors and Tretinoin Efficacy in Patients With Moderate to Severe Facial Photodamage: A Randomized Clinical Trial","volume":"158","author":"Chien","year":"2022","journal-title":"JAMA Dermatol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s40257-024-00893-w","article-title":"Comparing Tretinoin to Other Topical Therapies in the Treatment of Skin Photoaging: A Systematic Review","volume":"25","author":"Siddiqui","year":"2024","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_34","first-page":"864","article-title":"High-Strength Tretinoin for Rapid Retinization of Photoaged Facial Skin","volume":"30","author":"Kligman","year":"2004","journal-title":"Dermatol. Surg."},{"key":"ref_35","first-page":"1439","article-title":"Comparison between 1% tretinoin peeling versus 70% glycolic acid peeling in the treatment of female patients with melasma","volume":"10","author":"Faghihi","year":"2011","journal-title":"J. Drugs Dermatol. JDD"},{"key":"ref_36","first-page":"697","article-title":"A randomized controlled trial of the efficacy and safety of a fixed triple combination (fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05%) compared with hydroquinone 4% cream in Asian patients with moderate to severe melasma","volume":"159","author":"Chan","year":"2008","journal-title":"Br. J. Dermatol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s40261-015-0292-8","article-title":"Efficacy and Safety of Fluocinolone Acetonide, Hydroquinone, and Tretinoin Cream in Chinese Patients with Melasma: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group Study","volume":"35","author":"Gong","year":"2015","journal-title":"Clin. Drug Investig."},{"key":"ref_38","first-page":"47","article-title":"Treating epidermal melasma with a 4% hydroquinone skin care system plus tretinoin cream 0.025%","volume":"91","author":"Grimes","year":"2013","journal-title":"Cutis"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e70205","DOI":"10.1111\/jocd.70205","article-title":"Efficacy and Safety of Generic Fluocinolone Acetonide, Hydroquinone, and Tretinoin Cream Compared With TRI-LUMA for the Treatment of Moderate-To-Severe Melasma in Chinese Patients: A Randomized, Single-Center, Placebo-Controlled Trial","volume":"24","author":"Hu","year":"2025","journal-title":"J. Cosmet. Dermatol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/bjd.21244","article-title":"Self-applied topical interventions for melasma: A systematic review and meta-analysis of data from randomized, investigator-blinded clinical trials","volume":"187","author":"Pennitz","year":"2022","journal-title":"Br. J. Dermatol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s40257-021-00643-2","article-title":"Effects of Topical Retinoids on Acne and Post-inflammatory Hyperpigmentation in Patients with Skin of Color: A Clinical Review and Implications for Practice","volume":"23","author":"Callender","year":"2022","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jaad.2010.01.048","article-title":"Nonablative 1550-nm fractional laser therapy versus triple topical therapy for the treatment of melasma: A randomized controlled pilot study","volume":"64","author":"Kroon","year":"2011","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s10103-019-02944-9","article-title":"Comparison of the effectiveness of fractional 1550-nm erbium fiber laser and 0.05% tretinoin cream in the treatment of acanthosis nigricans: A prospective, randomized, controlled trial","volume":"35","author":"Leerapongnan","year":"2020","journal-title":"Lasers Med. Sci."},{"key":"ref_44","first-page":"862","article-title":"Benefits of using a hydroquinone\/tretinoin skin care system in patients undergoing intense pulsed light therapy for photorejuvenation: A placebo-controlled study","volume":"8","author":"Woodhall","year":"2009","journal-title":"J. Drugs Dermatol. JDD"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1177\/1090820X11411579","article-title":"Further Enhancement of Facial Appearance With a Hydroquinone Skin Care System Plus Tretinoin in Patients Previously Treated With Botulinum Toxin Type A","volume":"31","author":"Schlessinger","year":"2011","journal-title":"Aesthet. Surg. J."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s00403-022-02472-7","article-title":"Comparing the efficacy and safety profiles of 0.025% and 0.05% tretinoin creams in treating acanthosis nigricans: A randomized double-blinded study","volume":"315","author":"Kritsanaviparkporn","year":"2023","journal-title":"Arch. Dermatol. Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1080\/09546634.2019.1708855","article-title":"The randomized trials of 10% urea cream and 0.025% tretinoin cream in the treatment of acanthosis nigricans","volume":"32","author":"Treesirichod","year":"2021","journal-title":"J. Dermatol. Treat."},{"key":"ref_48","first-page":"170","article-title":"To compare the efficacy and safety of trichloroacetic acid peel with topical tretinoin in the treatment of acanthosis nigricans: A randomized controlled study","volume":"29","author":"Rajegowda","year":"2019","journal-title":"J. Pak. Assoc. Dermatol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/pde.13799","article-title":"Comparison of the efficacy and safety of 0.1% adapalene gel and 0.025% tretinoin cream in the treatment of childhood acanthosis nigricans","volume":"36","author":"Treesirichod","year":"2019","journal-title":"Pediatr. Dermatol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1111\/jocd.16224","article-title":"Comparison of efficacy and safety of tretinoin 0.05% and glycolic acid peeling 70% in axillary and neck lesions of acanthosis nigricans: A single-blinded, randomized trial","volume":"23","author":"Ghiasi","year":"2024","journal-title":"J. Cosmet. Dermatol."},{"key":"ref_51","first-page":"333","article-title":"A randomized, double-blind, placebo-controlled, pilot study to assess the efficacy and safety of clindamycin 1.2% and tretinoin 0.025% combination gel for the treatment of acne rosacea over 12 weeks","volume":"11","author":"Chang","year":"2012","journal-title":"J. Drugs Dermatol. JDD"},{"key":"ref_52","first-page":"1410","article-title":"Clindamycin phosphate 1.2% and tretinoin 0.025% gel for rosacea: Summary of a placebo-controlled, double-blind trial","volume":"11","author":"Freeman","year":"2012","journal-title":"J. Drugs Dermatol. JDD"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e22256","DOI":"10.1097\/MD.0000000000022256","article-title":"Comparative effectiveness of different therapies for treating striae distensae: A systematic review and network meta-analysis","volume":"99","author":"Lu","year":"2020","journal-title":"Medicine"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/jdv.13223","article-title":"Topical management of striae distensae (stretch marks): Prevention and therapy of striae rubrae and albae","volume":"30","author":"McGeorge","year":"2016","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/DSS.0000000000001408","article-title":"Platelet-Rich Plasma Versus Tretinoin in Treatment of Striae Distensae: A Comparative Study","volume":"44","author":"Gamil","year":"2018","journal-title":"Dermatol. Surg."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/dsu.12460","article-title":"Superficial Dermabrasion Versus Topical Tretinoin on Early Striae Distensae: A Randomized, Pilot Study","volume":"40","author":"Hexsel","year":"2014","journal-title":"Dermatol. Surg."},{"key":"ref_57","first-page":"600","article-title":"Comparison of efficacy of 30% solution of trichloroacetic acid (TCA) with 0.025% tretinoin in the treatment of flat warts at a tertiary care hospital","volume":"31","author":"Yousaf","year":"2022","journal-title":"J. Pak. Assoc. Dermatol."},{"key":"ref_58","first-page":"38","article-title":"Using a Hydroquinone\/Tretinoin-based Skin Care System Before and After Electrodesiccation and Curettage of Superficial Truncal Basal Cell Carcinoma","volume":"2","author":"David","year":"2009","journal-title":"J. Clin. Aesthetic Dermatol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1590\/S1807-59322011001100016","article-title":"Mechanical evaluation of the resistance and elastance of post-burn scars after topical treatment with tretinoin","volume":"66","author":"Dematte","year":"2011","journal-title":"Clinics"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s00266-004-0151-0","article-title":"Combined Tretinoin and Glycolic Acid Treatment Improves Mouth Opening for Postburn Patients","volume":"30","author":"Salles","year":"2006","journal-title":"Aesthetic Plast. Surg."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2165\/00128071-200708050-00003","article-title":"Efficacy of 5% Minoxidil versus Combined 5% Minoxidil and 0.01% Tretinoin for Male Pattern Hair Loss","volume":"8","author":"Shin","year":"2007","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/dth.12164","article-title":"Clinical utility and validity of minoxidil response testing in androgenetic alopecia","volume":"28","author":"Goren","year":"2015","journal-title":"Dermatol. Ther."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"e12915","DOI":"10.1111\/dth.12915","article-title":"Tretinoin enhances minoxidil response in androgenetic alopecia patients by upregulating follicular sulfotransferase enzymes","volume":"32","author":"Sharma","year":"2019","journal-title":"Dermatol. Ther."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"148","DOI":"10.4103\/0019-5154.62747","article-title":"Comparative Assessment of Topical Steroids, Topical Tretenoin (0.05%) and Dithranol Paste in Alopecia Areata","volume":"55","author":"Das","year":"2010","journal-title":"Indian J. Dermatol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1001\/archderm.141.11.1373","article-title":"The Effect of Short-Contact Topical Tretinoin Therapy for Foot Ulcers in Patients With Diabetes","volume":"141","author":"Tom","year":"2005","journal-title":"Arch. Dermatol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/ijd.14363","article-title":"A randomized, open, controlled trial of tretinoin 0.05% cream vs. low-dose oral isotretinoin for the treatment of field cancerization","volume":"58","author":"Ianhez","year":"2019","journal-title":"Int. J. Dermatol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1038\/jid.2011.483","article-title":"Tretinoin and the Prevention of Keratinocyte Carcinoma (Basal and Squamous Cell Carcinoma of the Skin): A Veterans Affairs Randomized Chemoprevention Trial","volume":"132","author":"Weinstock","year":"2012","journal-title":"J. Investig. Dermatol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"486","DOI":"10.36849\/JDD.7334","article-title":"Keratinocyte Carcinoma Chemoprevention With a Combination of Imiquimod, 5-Fluorouracil, and Tretinoin","volume":"22","author":"Nahm","year":"2023","journal-title":"J. Drugs Dermatol. JDD"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"260","DOI":"10.36849\/JDD.5427","article-title":"A Non-Surgical and Cost-Effective Treatment Approach Employing Topical Imiquimod, 5-Fluorouracil, and Tretinoin for Primary Non-Melanoma Skin Cancers","volume":"20","author":"Nahm","year":"2021","journal-title":"J. Drugs Dermatol. JDD"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jdcr.2020.07.024","article-title":"Treating keratinocyte carcinomas with a combination of imiquimod, 5-fluorouracil, and tretinoin using store-and-forward telemedicine in the age of coronavirus disease 2019 to promote social distancing","volume":"6","author":"Nahm","year":"2020","journal-title":"JAAD Case Rep."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/01.prs.0000293869.00522.ec","article-title":"Combined Therapy Using Q-Switched Ruby Laser and Bleaching Treatment with Tretinoin and Hydroquinone for Periorbital Skin Hyperpigmentation in Asians","volume":"121","author":"Momosawa","year":"2008","journal-title":"Plast. Reconstr. Surg."},{"key":"ref_72","first-page":"1001","article-title":"Combined Therapy Using Q-Switched Ruby Laser and Bleaching Treatment With Tretinoin and Hydroquinone for Acquired Dermal Melanocytosis","volume":"29","author":"Momosawa","year":"2003","journal-title":"Dermatol. Surg."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"139","DOI":"10.4103\/0974-2077.191653","article-title":"Retinoids: Literature Review and Suggested Algorithm for Use Prior to Facial Resurfacing Procedures","volume":"9","author":"Buchanan","year":"2016","journal-title":"J. Cutan. Aesthetic Surg."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/S0190-9622(97)70059-8","article-title":"The percutaneous absorption of topically applied tretinoin and its effect on endogenous concentrations of tretinoin and its metabolites after single doses or long-term use","volume":"36","author":"Latriano","year":"1997","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.jaad.2010.10.014","article-title":"Use of topical tretinoin and the development of noncutaneous adverse events: Evidence from a systematic review of the literature","volume":"65","author":"Shapiro","year":"2011","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/ajmg.a.30744","article-title":"Minor malformations characteristic of the retinoic acid embryopathy and other birth outcomes in children of women exposed to topical tretinoin during early pregnancy","volume":"136","author":"Loureiro","year":"2005","journal-title":"Am. J. Med. Genet. A"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1177\/0091270011429566","article-title":"Pregnancy Outcome Following Exposure to Topical Retinoids: A Multicenter Prospective Study","volume":"52","author":"Panchaud","year":"2012","journal-title":"J. Clin. Pharmacol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/S0140-6736(05)63790-7","article-title":"Safety of first-trimester exposure to topical tretinoin: Prospective cohort study","volume":"350","author":"Shapiro","year":"1997","journal-title":"Lancet"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/0140-6736(93)91004-6","article-title":"First trimester topical tretinoin and congenital disorders","volume":"341","author":"Jick","year":"1993","journal-title":"Lancet"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1006.e1","DOI":"10.1016\/j.jaad.2023.12.017","article-title":"Guidelines of care for the management of acne vulgaris","volume":"90","author":"Reynolds","year":"2024","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1503\/cmaj.140665","article-title":"Management of acne: Canadian clinical practice guideline","volume":"188","author":"Asai","year":"2016","journal-title":"CMAJ"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2165\/0128071-200809060-00003","article-title":"Topical retinoids in acne vulgaris: Update on efficacy and safety","volume":"9","author":"Thielitz","year":"2008","journal-title":"Am. J. Clin. Dermatol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/22\/7958\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T05:10:50Z","timestamp":1762924250000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/22\/7958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,10]]},"references-count":82,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["jcm14227958"],"URL":"https:\/\/doi.org\/10.3390\/jcm14227958","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,10]]}}}